Date/Time: 03/23/2017, 9:00 am - 4:30 pm
Thursday, March 23, 2017
9:00 am – 10:30 am HST
11:00 am – 12:30 pm AKT
12:00 pm – 1:30 pm PT
1:00 pm – 2:30 pm MT
2:00 pm – 3:30 pm CT
3:00 pm – 4:30 pm ET
Prosecuting healthcare fraud is a top priority of government enforcement agencies. Directors and managers of healthcare organizations have important responsibilities regarding compliance and investigation of corporate misconduct. Recent government guidance and enforcement actions have placed increased focus on individual liability for corporate wrongdoing. Consequently, it is essential for corporate board members to have a basic understanding of their fiduciary obligations and how to properly exercise their duty of care in overseeing a healthcare organization’s compliance program.
This webinar will address recent enforcement actions and guidance issued by the Department of Health and Human Services Office of Inspector General and the Department of Justice regarding board fiduciary duties for ensuring an effective compliance program and the standards for holding individuals liable for corporate wrongdoing.
- Elements and structure of an effective corporate compliance program
- Corporate board member’s duty of care
- Oversight responsibilities for healthcare governing boards
- DOJ’s 2015 Yates Memo – guidance on individual accountability for corporate misconduct
- Recent enforcement actions and court decisions involving board member and manager liability
- TAKE-AWAY TOOLKIT
- Hospice and home health risk areas
- Links to government documents regarding board responsibilities and individual liability
WHO SHOULD ATTEND?
This informative session is designed for corporate board members, executives, administrators, and hospice and home health agency managers.
PLEASE NOTE: Webinar content is subject to copyright and intended for your individual organization’s use only.